₹20.4
■ +0 +0.00%
As of 16 Oct 2026 · delayed
BSE Listed
Vanta Bioscience Limited (540729)
Volume: 1,500Avg Vol 1W: 2,400Avg Vol 1M: 1,94352W Range:₹14.71₹29
Key Ratios
Checked just nowMarket Cap₹15 Cr
Current Price₹20.4
Previous Close₹20.4
High / Low (52w)₹29 / ₹14.71
Volume1,500
Avg Vol (1W)2,400
Avg Vol (1M)1,943
Stock P/E136
Book Value₹29.77
Dividend Yield0%
ROE51.14%
ROA0%
Revenue (TTM)—
Revenue Growth—
Profit Margin-113.62%
Total Debt—
Shares Outstanding1 Cr
Face Value—
EPS (TTM)₹0.15
P/B0.69
Debt / Equity5.11
50 DMA₹21.09
200 DMA₹22.29
Day change+0.00%
Price Chart
₹20.4▼ 5.82% · 1Y
2025-10-302026-10-16
20-day avg volume: 2K shares
Pros
- Healthy return on equity of 51.1%.
- Company is almost debt-free.
- Stock trades below its book value.
Cons
- Revenue fell 79% YoY.
- Company is loss-making at the latest annual result.
- Stock trades at a high P/E of 136.
Quarterly Results
| Metric | Dec 2022 |
|---|---|
| Revenue | ₹3 Cr |
| EBITDA | ₹-2 Cr |
| Net Profit | ₹-3 Cr |
| EPS | — |
Profit & Loss (Annual)
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Dec 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹13 Cr | ₹14 Cr | ₹10 Cr | ₹10 Cr | ₹2 Cr | ₹7 Cr | ₹10 Cr | ₹2 Cr |
| EBITDA | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹0 Cr | ₹-4 Cr | ₹-3 Cr | ₹-9 Cr |
| Net Profit | ₹1 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹-2 Cr | ₹-6 Cr | ₹-2 Cr | ₹-5 Cr |
| EPS | 1.1 | 1.59 | 0.71 | 0.14 | — | -10.27 | -3.67 | -7.56 |
Balance Sheet
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|
| Total Assets | ₹39 Cr | ₹49 Cr | ₹70 Cr | ₹81 Cr | ₹85 Cr | ₹85 Cr | ₹86 Cr |
| Total Liabilities | ₹16 Cr | ₹24 Cr | ₹43 Cr | ₹52 Cr | ₹66 Cr | ₹72 Cr | ₹82 Cr |
| Equity | ₹23 Cr | ₹24 Cr | ₹26 Cr | ₹29 Cr | ₹19 Cr | ₹13 Cr | ₹4 Cr |
| Total Debt | — | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|---|
| Operating | ₹-1 Cr | ₹2 Cr | ₹7 Cr | ₹5 Cr | ₹-1 Cr | ₹3 Cr |
| Investing | ₹-5 Cr | ₹-7 Cr | ₹-22 Cr | ₹-17 Cr | ₹-6 Cr | ₹-3 Cr |
| Financing | ₹10 Cr | ₹2 Cr | ₹18 Cr | ₹10 Cr | ₹6 Cr | ₹1 Cr |
| Free Cash Flow | ₹-1 Cr | ₹2 Cr | ₹7 Cr | ₹5 Cr | ₹-1 Cr | ₹3 Cr |
Shareholding
Promoter 72.81% Institutions 0% Public 27.19%
Efficiency & Working Capital
ROCE1.3%
Interest Coverage-2.1
Dividend Payout—
Debtor Days465 d
Inventory Days1210 d
Payable Days919 d
Cash Conversion Cycle756 d
Working Capital Days1675 d
Shareholding Details
As of 2026-09-30
Promoter72.8%
FII0%
DII0%
Institutions0%
Public27.2%
Promoter Pledge0%
No. of Shareholders426
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Sept 2021 | Mar 2022 | Sept 2022 | Mar 2023 | Sept 2023 | Mar 2024 | Sept 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Mar 2026 | Sept 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 69% | 69% | 69.4% | 69.4% | 69.4% | 69.4% | 69.4% | 69.4% | 72.8% | 72.8% | 72.8% | 72.8% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 31% | 31% | 30.6% | 30.6% | 30.6% | 30.6% | 30.6% | 30.6% | 27.2% | 27.2% | 27.2% | 27.2% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 412 | 409 | 393 | 394 | 388 | 418 | 424 | 408 | 408 | 419 | 426 | 426 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202503 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Mohan Krishna Mulakala | Shareholding of Promoter and Promoter Group | 49% | 34,85,500 |
| Dopesh Raja Mulakala | Shareholding of Promoter and Promoter Group | 12.1% | 8,58,000 |
| S Chandra Sekhar Rao | Shareholding of Promoter and Promoter Group | 7.4% | 5,22,500 |
| Soumya Simhadri | Shareholding of Promoter and Promoter Group | 1.3% | 90,100 |
| Shravan Chintapatla | Shareholding of Promoter and Promoter Group | 1.1% | 80,100 |
| Vyasmurti Madhavrao Shingatgeri | Shareholding of Promoter and Promoter Group | 0.7% | 50,000 |
| Mulakala Karishma | Shareholding of Promoter and Promoter Group | 0.7% | 50,100 |
| Pradeep Chowdary Veeramachineni | Shareholding of Promoter and Promoter Group | 0.3% | 21,500 |
| M Sajan Kiran | Shareholding of Promoter and Promoter Group | 0.3% | 20,100 |
| Sujana Sheela Mulakala | Shareholding of Promoter and Promoter Group | 0% | 100 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Dopesh Raja Mulakala | Managing Director | 2025 |
| Padmanabhuni Venkata Appaji | Independent Non Exe. Director | 2025 |
| Kathyayani Gonuguntla | Independent Non Exe. Director | 2025 |
| Yogeswara Rao Danda | Independent Non Exe. Director | 2025 |
| Pooja Kothari | Company Sec. & Compli. Officer | 2025 |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2025 | ₹10 | 8 | 6 | 6 |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2025 | 1 | 0 | 0 | 7 | 21 | 29 |
| 2025 | 1 | 0 | 0 | 7 | 18 | 26 |
| 2025 | 0 | 0 | 0 | 0 | 3 | 3 |
Substantial Acquisitions (SAST)
1 disclosure(s)
Pref. Allotment06/05/2025 · 8,00,000
Company Information
🌐 www.vantabio.com ↗
📍 No.02/G/308/G Umajay Complex, Rasoolpura Secunderabad, Hyderabad, Telangana, 500003
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Aayush Art and Bullion LimitedSBI Life InsuranceShare India SecuritiesTrident Texofab LimitedPoojawestern Metaliks LimitedSayaji Industries LimitedMehai Technology LimitedIRIS RegTech SolutionsShree Ganesh Remedies LimitedShreeji Translogistics LimitedMAS Financial ServicesIndian Energy ExchangeAll “54” stocks →
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search